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Evidence Code
Ontology (ECO)
ECO is a rich ontology
for experimental and
other evidence
statements currently
available from the OBO
CVS repository.
Some ECO terms.
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Development of an Ontology of Microbial Phenotypes (OMP)
Abstract
Phenotypic data are routinely used to elucidate gene and protein
function in most organisms amenable to experimental manipulation.
However, although phenotype ontologies exist for many eukaryotic
model organisms, no standardized system exists for the capture of
phenotypic information in bacteria. We propose to build an Ontology of
Microbial Phenotypes and use it to annotate the prokaryotic model
organism Escherichia coli.
Introduction
Phenotypes are the observable characteristics of an organism that
result from the combination of a particular genotype and a particular
environment, and thus are a basic and fundamental aspect of the
biology of all organisms. The awesome power of genetics is
founded on how the phenotypes of mutant genes, alone and in
combination, contribute to understanding the biology of affected
systems. To fully exploit the power of phenotypes for functional and
comparative genomics, the ability to make comparisons across
datasets and systems is vital. Making these comparisons either
manually or computationally is hindered by the fact that phenotypes
are not described consistently for bacteria. Our project aims to
develop annotation infrastructure to improve the ability of
microbiologists and bioinformaticians to use both existing and new
phenotype information and to capture it in a consistent and
standardized manner. This will require two key components: 1) an
Ontology of Microbial Phenotypes (OMP) that captures phenotype
descriptions in a controlled vocabulary, and 2) a set of evidence
codes based on extension of the existing Evidence Code Ontology,1
with links to a database of papers and other resources describing
the assays used to “measure” these phenotypes.
Methods
We have explored two parallel approaches to building the OMP. Both are pre-coordinated approaches
that rely on using the terms in the Phenotypic Quality Ontology (PATO) as a basis for building up
phenotype terms.2 In the first approach we read 100 papers and identified 40 phenotypes described in
those papers. We organized the 40 phenotypes into a controlled vocabulary using OBO-Edit.3 While
this effort was not comprehensive, we were able to classify the 40 phenotypes into five superclasses
and assign PATO entities and qualities. In addition, various assays (biochemical, morphological, and
physiological) were collected from the papers that were curated to generate phenotype terms.  In the
second approach we generated a cross product between a selection of PATO terms and two GO nodes
relevant to microbial phenotypes, “GO:0044262 : cellular carbohydrate metabolic process” and
“GO:0006520 : cellular amino acid metabolic process.” We found the cross product generation method
to be quite effective in generating large numbers of relevant terms quickly.
Query PubMed for
Escherichia coli with
keywords "mutation
AND phenotype” (i.e.
"txid562[Organism:e
xp] AND mutation
AND phenotype”)
Read 100 papers
Collect assays
Develop terms
Five superclasses of manually
assessed phenotype terms
E. coli phenotype assays
Conclusion
The manual and cross product efforts were undertaken
independently and in parallel by separate members of the group to
see what, if any, consistency would be achieved. We found that
although the concepts captured were similar, the different
researchers chose different PATO quality terms to represent the
same concepts. The manual curator chose “abnormal,” while the
person working on cross products chose “abolished” and
“disrupted.” The results of this exercise illustrate one reason why
the pre-coordinated approach has advantages over the post-
coordinated approach. In the post-coordinated approach separate
annotators creating phenotype annotations at different points in
time may choose different ways of expressing the same concept
and thus create inconsistency. In the pre-coordinated approach,
one controlled set of PATO terms will be used for term generation,
and the fact of storing all the terms in one controlled vocabulary will
enforce consistency and uniformity.
Future Directions
If our project is funded, we plan to expand our cross product
generation by targeting relevant nodes in the GO and other
ontologies.  We will extend ECO to include terms that capture the
assays used in phenotype analysis. We will apply the OMP and
extended ECO to the annotation of Eschericia coli and make the
data available using EcoliWiki and other resources.
Manually Derived
Cross Products
Combining a quality
term from PATO with an
entity term from GO
creates a new term that
describes a phenotype.
Example:
“disrupted” x  “amino acid
metabolic process” =
“disrupted amino acid
metabolic process”
Some PATO terms.
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